MedTrace Logo

A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites

NCT06415500 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2024-05-16

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of NK042 for treatment of malignant ascites.

Conditions

  • Gynecologic Cancer

Interventions

DRUG

NK042

NK042 intraperitoneal infusion on Days 0,7 and 14.

Sponsors & Collaborators

  • Anhui Provincial Hospital

    lead OTHER_GOV

Principal Investigators

  • Ying Zhou, MD · The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-06
Primary Completion
2025-12-06
Completion
2026-12-06

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06415500 on ClinicalTrials.gov